[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.127.188. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 3, 1999

Hormone Replacement Therapy for Secondary Prevention of Coronary Heart Disease

Author Affiliations
 

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;281(9):794-797. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-9-jbk0303

To the Editor: We commend Dr Hulley and colleagues1 on a well-designed, first-ever randomized trial to evaluate continuous estrogen-progestin hormone replacement therapy (HRT) for the secondary prevention of coronary heart disease (CHD). Surprisingly and disturbingly, the results do not support the beneficial effects of HRT found in observational studies.

First Page Preview View Large
First page PDF preview
First page PDF preview
×